Cargando…
Neuroinflammation in Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disease associated with human aging. Ten percent of individuals over 65 years have AD and its prevalence continues to rise with increasing age. There are currently no effective disease modifying treatments for AD, resulting in increasingly large socioe...
Autores principales: | Onyango, Isaac G., Jauregui, Gretsen V., Čarná, Mária, Bennett, James P., Stokin, Gorazd B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150909/ https://www.ncbi.nlm.nih.gov/pubmed/34067173 http://dx.doi.org/10.3390/biomedicines9050524 |
Ejemplares similares
-
Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021) -
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases
por: Onyango, Isaac G., et al.
Publicado: (2021) -
Mitochondrial behavior when things go wrong in the axon
por: Pozo Devoto, Victorio M., et al.
Publicado: (2022) -
Unraveling axonal mechanisms of traumatic brain injury
por: Pozo Devoto, Victorio M., et al.
Publicado: (2022) -
Neuroinflammation in Alzheimer’s disease
por: Zhang, Fengjin, et al.
Publicado: (2015)